全文获取类型
收费全文 | 694篇 |
免费 | 27篇 |
国内免费 | 4篇 |
专业分类
儿科学 | 3篇 |
妇产科学 | 1篇 |
基础医学 | 11篇 |
临床医学 | 103篇 |
内科学 | 316篇 |
神经病学 | 7篇 |
特种医学 | 13篇 |
外科学 | 84篇 |
综合类 | 68篇 |
预防医学 | 5篇 |
药学 | 85篇 |
中国医学 | 26篇 |
肿瘤学 | 3篇 |
出版年
2024年 | 2篇 |
2023年 | 13篇 |
2022年 | 9篇 |
2021年 | 14篇 |
2020年 | 20篇 |
2019年 | 122篇 |
2018年 | 135篇 |
2017年 | 37篇 |
2016年 | 12篇 |
2015年 | 9篇 |
2014年 | 41篇 |
2013年 | 29篇 |
2012年 | 22篇 |
2011年 | 48篇 |
2010年 | 26篇 |
2009年 | 25篇 |
2008年 | 46篇 |
2007年 | 61篇 |
2006年 | 8篇 |
2005年 | 14篇 |
2004年 | 5篇 |
2003年 | 2篇 |
2002年 | 3篇 |
2001年 | 5篇 |
2000年 | 4篇 |
1999年 | 7篇 |
1997年 | 1篇 |
1995年 | 1篇 |
1991年 | 2篇 |
1988年 | 1篇 |
1984年 | 1篇 |
排序方式: 共有725条查询结果,搜索用时 15 毫秒
1.
目的:系统评价丹红注射液对急性心肌梗死(AMI)经皮冠状动脉介入治疗(PCI)围手术期心功能和心肌梗塞溶栓治疗(TIMI)血流分级的影响。方法:计算机检索CNKI,万方数据库,维普数据库,Pub Med,CBM,Web of Science,The Cochrane Library共7个数据库,全面采集在PCI围手术期应用丹红注射液治疗急性心梗的临床试验,采用Cochrane风险评价表进行文献质量评价,运用Revman 5.3软件进行Meta分析。结果:共纳入12个临床试验,包含1131例患者,其中丹红治疗组569例,对照组562例,结果显示在常规治疗的基础上加入丹红注射液治疗,患者的左室射血分数明显增高[均数差(MD)=6.62,95%可信区间(CI)(4.91,8.34),P<0.00001],TIMI分级3级患者明显增多[相对危险度(RR)=0.22,95%CI(0.12,0.41),P<0.00001],脑利钠肽水平明显降低[MD=-151.86,95%CI(-247.00,-56.72),P=0.002]。结论:丹红注射液可以提高急性心梗PCI围手术期心功能和增加TIMI血流的分级。 相似文献
2.
目的:通过对生脉养心颗粒的临床观察,探讨生脉养心颗粒治疗老年慢性心力衰竭(Chronic Heart Failure,CHF)患者的治疗效果,并预测其远期临床获益。方法:将120例中医辨证分型为气阴两虚型的老年慢性心力衰竭患者随机分为两组,治疗组60例,对照组60例。对照组给予单纯的常规西药治疗,治疗组在常规西药治疗的基础上加用生脉养心颗粒治疗,两组治疗时间均为24个月。观察两组患者临床疗效,检测用药不同时间(分别于第3、12、24个月末)治疗前后B型脑钠肽(BNP)、左室射血分数(Left Ventricular Ejection Fracfion,LVEF)、6分钟步行试验(6-minute walk Test,6MWT)等疗效指标的变化,并且随访两组患者再入院率与病死率。结果:24个月后治疗组总有效率为86.7%(52/60),优于对照组的68.3%(41/60),两组差异比较有统计学意义(P<0.05)。治疗后两组BNP、LVEF、6MWT较治疗前均有明显改善(P<0.01)。组间比较:治疗3、12、24个月后BNP比较,治疗组优于对照组,差异有统计学意义(P<0.01)或(P<0.05)。治疗3个月后LVEF比较,两组间差异无统计学意义(P>0.05);治疗12、24个月后,治疗组LVEF优于对照组,两组差异有统计学意义(P<0.05)。治疗3、12、24个月后,治疗组6MWT优于对照组,比较差异有统计学意义(P<0.01)。随访2年,治疗组的再入院率和病死率显著低于对照组,组间差异有统计学意义(P<0.05)。结论:生脉养心颗粒能够改善老年慢性心力衰竭患者心功能及预后,提高其临床疗效,值得在临床推广应用。 相似文献
3.
4.
John Aalen Petter Storsten Espen W. Remme Per A. Sirnes Ola Gjesdal Camilla K. Larsen Erik Kongsgaard Espen Boe Helge Skulstad Jonny Hisdal Otto A. Smiseth 《JACC: Cardiovascular Imaging》2019,12(6):967-977
ObjectivesThis study sought to investigate the hypothesis that patients with left bundle branch block (LBBB) are hypersensitive to elevated afterload.BackgroundEpidemiological data suggest that LBBB can provoke heart failure in patients with hypertension.MethodsIn 11 asymptomatic patients with isolated LBBB and 11 age-matched control subjects, left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) were measured by echocardiography. Systolic arterial pressure was increased by combining pneumatic extremity constrictors and handgrip exercise. To obtain more insight into mechanisms of afterload response, 8 anesthetized dogs with left ventricular (LV) micromanometer and dimension crystals were studied during acutely induced LBBB and aortic constriction. Regional myocardial work was assessed by LV pressure-dimension analysis.ResultsConsistent with normal afterload dependency, elevation of systolic arterial pressure by 38 ± 12 mm Hg moderately reduced LVEF from 60 ± 4% to 54 ± 6% (p < 0.01) in control subjects. In LBBB patients, however, a similar blood pressure increase caused substantially larger reduction in LVEF (p < 0.01), from 56 ± 6% to 42 ± 7% (p < 0.01). There were similar findings for GLS. In the dog model, aortic constriction abolished septal shortening (p < 0.02), and septal work decreased to negative values (p < 0.01). Therefore, during elevated systolic pressure, the septum made no contribution to global LV work, as indicated by net negative work, and instead absorbed energy from work done by the LV lateral wall.ConclusionsModerate elevation of arterial pressure caused marked reductions in LVEF and GLS in patients with LBBB. This reflects a cardiodepressive effect of elevated afterload in the dyssynchronous ventricle and was attributed to loss of septal function. 相似文献
5.
6.
Claudia L. Zeballos-Palacios Ian G. Hargraves Peter A. Noseworthy Megan E. Branda Marleen Kunneman Bruce Burnett Michael R. Gionfriddo Christopher J. McLeod Haeshik Gorr Juan Pablo Brito Victor M. Montori 《Mayo Clinic proceedings. Mayo Clinic》2019,94(4):686-696
Patient-centered care requires that treatments respond to the problematic situation of each patient in a manner that makes intellectual, emotional, and practical sense, an achievement that requires shared decision making (SDM). To implement SDM in practice, tools—sometimes called conversation aids or decision aids—are prepared by collating, curating, and presenting high-quality, comprehensive, and up-to-date evidence. Yet, the literature offers limited guidance for how to make evidence support SDM. Herein, we describe our approach and the challenges encountered during the development of Anticoagulation Choice, a conversation aid to help patients with atrial fibrillation and their clinicians jointly consider the risk of thromboembolic stroke and decide whether and how to respond to this risk with anticoagulation. 相似文献
7.
Eri Minamino-Muta Takao Kato Takeshi Morimoto Tomohiko Taniguchi Chisato Izumi Kenji Nakatsuma Moriaki Inoko Shinichi Shirai Norio Kanamori Koichiro Murata Takeshi Kitai Yuichi Kawase Makoto Miyake Hirokazu Mitsuoka Yutaka Hirano Tomoki Sasa Kazuya Nagao Tsukasa Inada Takeshi Kimura 《JACC: Cardiovascular Interventions》2019,12(24):2499-2511
ObjectivesThe aim of this study was to investigate the prognostic impact of the decline in left ventricular ejection fraction (LVEF) at 1-year follow-up in patients with severe aortic stenosis (AS) managed conservatively.BackgroundNo previous study has explored the association between LVEF decline during follow-up and clinical outcomes in patients with severe AS.MethodsAmong 3,815 patients with severe AS enrolled in the multicenter CURRENT AS (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis) registry in Japan, 839 conservatively managed patients who underwent echocardiography at 1-year follow-up were analyzed. The primary outcome measure was a composite of AS-related deaths and hospitalization for heart failure.ResultsThere were 91 patients (10.8%) with >10% declines in LVEF and 748 patients (89.2%) without declines. Left ventricular dimensions and the prevalence of valve regurgitation and atrial fibrillation or flutter significantly increased in the group with declines in LVEF. The cumulative 3-year incidence of the primary outcome measure was significantly higher in the group with declines in LVEF than in the group with no decline (39.5% vs. 26.5%; p < 0.001). After adjusting for confounders, the excess risk of decline in LVEF over no decline for the primary outcome measure remained significant (hazard ratio: 1.98; 95% confidence interval: 1.29 to 3.06). When stratified by LVEF at index echocardiography (≥70%, 60% to 69%, and <60%), the risk of decline in LVEF on the primary outcome was consistently seen in all the subgroups, without any interaction (p = 0.77).ConclusionsPatients with severe AS with >10% declines in LVEF at 1 year after diagnosis had worse AS-related clinical outcomes than those without declines in LVEF under conservative management. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140) 相似文献
8.
Yuhei Ito Motoaki Tanigawa Keisuke Iwamoto Akina Nigi Hidetoshi Itani Shigeto Kondo Toshiya Tokui Eiji Usui Shigehisa Tamaki 《Respiratory investigation》2019,57(5):506-509
Dasatinib has increasingly been used to treat chronic myeloid leukemia (CML), although interstitial pneumonitis has been found as a complication in large clinical trials. In the present study, 23 patients received dasatinib for CML between 2012 and 2017 at our institution, of whom 2 developed symptomatic interstitial pneumonitis. Notably, the first patient developed interstitial pneumonitis five years after initiating dasatinib. Interstitial pneumonitis should be considered as a complication in patients receiving dasatinib for CML, which may even occur after a long period of uncomplicated administration. 相似文献
9.
Hang Zhang Juan Zhang Mengxuan Chen Du-Jiang Xie Jing Kan Wande Yu Xiao-Bo Li Tian Xu Yue Gu Jianzeng Dong Hong Gu Yaling Han Shao-Liang Chen 《JACC: Cardiovascular Interventions》2019,12(3):274-284